Insmed (INSM) PT Raised to $108 at RBC Capital
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $117.83 -3.06%
Rating Summary:
32 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
32 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
RBC Capital analyst Leonid Timashev raised the price target on Insmed (NASDAQ: INSM) to $108.00 (from $106.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Goldman Sachs Assumes Insmed (INSM) at Buy
- HCL Technologies (HCLT:IN) PT Lowered to INR1,395 at UBS
- LTIMindtree Ltd (LTIM:IN) PT Lowered to INR3,620 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
